• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CLN3基因缺陷杂合子中的严重婴儿神经视网膜功能障碍。

Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.

作者信息

de los Reyes Emily, Dyken Paul Richard, Phillips Paul, Brodsky Michael, Bates Stephen, Glasier Charles, Mrak Robert E

机构信息

Department of Pediatrics, University of Arkansas for the Medical Sciences, Little Rock, USA.

出版信息

J Child Neurol. 2004 Jan;19(1):42-6. doi: 10.1177/08830738040190010703.

DOI:10.1177/08830738040190010703
PMID:15032383
Abstract

The neuronal ceroid-lipofuscinoses are a group of diseases that are characterized by progressive neuroretinal symptomatology, progressive accumulation of autofluorescing waxy lipopigments (ceroid-lipofuscin) within the brain and other tissues, and cerebral atrophy. Juvenile neuronal ceroid-lipofuscinosis, or Batten disease, is a form of neuronal ceroid-lipofuscinosis that is characterized by onset of neuroretinal symptoms between 4 and 10 years. Juvenile neuronal ceroid-lipofuscinosis is the most common type of neuronal ceroid-lipofuscinosis in the United States and Europe and is inherited as an autosomal recessive genetic disorder. Research in the last decade has led to the identification of the responsible gene for juvenile neuronal ceroid-lipofuscinosis, which is designated as CLN3. CLN3 is located on chromosome 16p11.2-12.1. The major mutation is a 1.02 kb deletion, which removes exons 7 and 8. Both homozygotic and heterozygotic deletions at the CLN3 gene site have been associated with the clinical syndromes of juvenile neuronal ceroid-lipofuscinosis. We report a possible atypical case of neuronal ceroid-lipofuscinosis, an infant, who presented at 5 months of age with a lack of developmental milestones, poor vision, severe retinopathy, intractable seizures, and progressive cerebral atrophy. Extensive laboratory investigations, including thorough metabolic evaluations, were unremarkable except for neuroimaging studies, electroencephalography, and electroretinography, all of which showed abnormalities confirming both cerebral and retinal degeneration. Although skin and conjunctival biopsies did not show classic fingerprint cytosomes by electron microscopic study, which characterize juvenile neuronal ceroid-lipofuscinosis, a diagnosis of an atypical form of juvenile neuronal ceroid-lipofuscinosis was suspected on the basis of the clinical picture. The retinal abnormalities, surprisingly, were those believed to be diagnostic of juvenile-onset neuronal ceroid-lipofuscinosis, or Batten disease. Subsequently, a heterozygous mutation for the common 1.02 kb deletion characteristic of juvenile neuronal ceroid-lipofuscinosis was established.

摘要

神经元蜡样脂褐质沉积症是一组以进行性神经视网膜症状、大脑及其他组织中自发荧光的蜡样脂色素(蜡样脂褐质)进行性蓄积以及脑萎缩为特征的疾病。青少年型神经元蜡样脂褐质沉积症,即巴滕病,是神经元蜡样脂褐质沉积症的一种形式,其特征为在4至10岁之间出现神经视网膜症状。青少年型神经元蜡样脂褐质沉积症是美国和欧洲最常见的神经元蜡样脂褐质沉积症类型,为常染色体隐性遗传疾病。过去十年的研究已确定青少年型神经元蜡样脂褐质沉积症的致病基因,命名为CLN3。CLN3位于16号染色体的p11.2 - 12.1区域。主要突变是一个1.02 kb的缺失,该缺失去除了第7和第8外显子。CLN3基因位点的纯合和杂合缺失均与青少年型神经元蜡样脂褐质沉积症的临床综合征相关。我们报告了一例可能的非典型神经元蜡样脂褐质沉积症病例,为一名婴儿,5个月大时出现发育里程碑缺失、视力差、严重视网膜病变、顽固性癫痫发作以及进行性脑萎缩。广泛的实验室检查,包括全面的代谢评估,除神经影像学检查、脑电图和视网膜电图外均无异常,所有这些检查均显示异常,证实了脑和视网膜的退化。尽管皮肤和结膜活检在电子显微镜检查中未显示青少年型神经元蜡样脂褐质沉积症所特有的典型指纹状细胞体,但根据临床表现怀疑为青少年型神经元蜡样脂褐质沉积症的非典型形式。令人惊讶的是,视网膜异常被认为是青少年发病的神经元蜡样脂褐质沉积症即巴滕病的诊断依据。随后,确定了青少年型神经元蜡样脂褐质沉积症常见的1.02 kb缺失的杂合突变。

相似文献

1
Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.CLN3基因缺陷杂合子中的严重婴儿神经视网膜功能障碍。
J Child Neurol. 2004 Jan;19(1):42-6. doi: 10.1177/08830738040190010703.
2
Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.青少年神经元蜡样脂褐质沉积症(巴滕病):同胞对中具有不同表型且体内自发荧光强度较低的CLN3突变(16号染色体p11.2)
Klin Monbl Augenheilkd. 2004 May;221(5):427-30. doi: 10.1055/s-2004-812819.
3
A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis.CLN3基因中一种新的c.1135_1138delCTGT突变导致青少年神经元蜡样脂褐质沉积症。
J Child Neurol. 2013 Sep;28(9):1112-6. doi: 10.1177/0883073813494812. Epub 2013 Jul 22.
4
Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).与新型CLN3突变(p.Y199X)相关的青少年蜡样脂褐质沉积症的病程迁延
Clin Genet. 2009 Jul;76(1):38-45. doi: 10.1111/j.1399-0004.2009.01179.x. Epub 2009 May 21.
5
Clinical and molecular characterization of non-syndromic retinal dystrophy due to c.175G>A mutation in ceroid lipofuscinosis neuronal 3 (CLN3).由于神经蜡样脂褐质沉积症3型(CLN3)基因c.175G>A突变导致的非综合征性视网膜营养不良的临床和分子特征
Doc Ophthalmol. 2019 Feb;138(1):55-70. doi: 10.1007/s10633-018-9665-7. Epub 2018 Nov 16.
6
The neuronal ceroid-lipofuscinoses.神经元蜡样脂褐质沉积症
J Child Neurol. 1995 Nov;10(6):424-37. doi: 10.1177/088307389501000602.
7
Deterioration of visual quality and acuity as the first sign of ceroid lipofuscinosis type 3 (CLN3), a rare neurometabolic disease.视觉质量和敏锐度下降是 3 型神经鞘脂褐质沉积症(CLN3)的首发症状,这是一种罕见的神经代谢疾病。
Metab Brain Dis. 2023 Feb;38(2):709-715. doi: 10.1007/s11011-022-01148-5. Epub 2022 Dec 28.
8
Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspective.神经元蜡样脂褐质沉积症小鼠模型中的脑区萎缩:一种新的前后视角
J Child Neurol. 2013 Sep;28(9):1117-22. doi: 10.1177/0883073813494479.
9
Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.CLN3 基因的缺失是少年神经元蜡样脂褐质沉积症的致病基因,会导致视网膜色素上皮的代谢损伤和自噬诱导。
Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165883. doi: 10.1016/j.bbadis.2020.165883. Epub 2020 Jun 25.
10
A novel in-frame mutation in leads to Juvenile neuronal ceroid lipofuscinosis in a large Pakistani family.一个新的帧内突变导致一个大型巴基斯坦家族中的少年神经元蜡样脂褐质沉积症。
Int J Neurosci. 2019 Sep;129(9):890-895. doi: 10.1080/00207454.2019.1586686. Epub 2019 Mar 20.

引用本文的文献

1
Detection of Structural Variants by NGS: Revealing Missing Alleles in Lysosomal Storage Diseases.通过二代测序检测结构变异:揭示溶酶体贮积症中的缺失等位基因
Biomedicines. 2022 Jul 29;10(8):1836. doi: 10.3390/biomedicines10081836.
2
Three case reports of patients indicating the diversity of molecular and clinical features of 16p11.2 microdeletion anomaly.三例患者病例报告表明了 16p11.2 微缺失异常的分子和临床特征的多样性。
BMC Med Genomics. 2021 Mar 10;14(1):76. doi: 10.1186/s12920-021-00929-8.
3
Gene correction of the CLN3 c.175G>A variant in patient-derived induced pluripotent stem cells prevents pathological changes in retinal organoids.
在患者来源的诱导多能干细胞中纠正 CLN3 c.175G>A 变异可防止视网膜类器官的病理变化。
Mol Genet Genomic Med. 2021 Mar;9(3):e1601. doi: 10.1002/mgg3.1601. Epub 2021 Jan 26.
4
The CLN3 gene and protein: What we know.CLN3 基因及蛋白:我们已知的知识。
Mol Genet Genomic Med. 2019 Dec;7(12):e859. doi: 10.1002/mgg3.859. Epub 2019 Sep 30.
5
CRISPR-Cas9-Mediated Correction of the 1.02 kb Common Deletion in in Induced Pluripotent Stem Cells from Patients with Batten Disease.CRISPR-Cas9介导的对巴顿病患者诱导多能干细胞中1.02 kb常见缺失的校正。
CRISPR J. 2018 Feb;1(1):75-87. doi: 10.1089/crispr.2017.0015.
6
Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal Degeneration.利用患者特异性诱导多能干细胞和野生型小鼠开发一种基于基因增强的策略来治疗CLN3相关的视网膜变性。
Hum Gene Ther. 2016 Oct;27(10):835-846. doi: 10.1089/hum.2016.049. Epub 2016 Jul 11.
7
Using Stem Cells to Model Diseases of the Outer Retina.利用干细胞构建视网膜外层疾病模型。
Comput Struct Biotechnol J. 2015 May 6;13:382-9. doi: 10.1016/j.csbj.2015.05.001. eCollection 2015.
8
Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye.青少年神经元蜡样脂褐质沉积症(JNCL)与眼睛。
Surv Ophthalmol. 2009 Jul-Aug;54(4):463-71. doi: 10.1016/j.survophthal.2009.04.007.
9
Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.神经元蜡样脂褐质沉积症中基因型、超微结构形态与临床表型之间的相关性
Neurogenetics. 2005 Sep;6(3):107-26. doi: 10.1007/s10048-005-0218-3. Epub 2005 Sep 28.